News
Weight loss can reverse the cardiovascular changes that take place in the heart, but will a new diet and exercise work, or is ...
If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...
Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have shed half their ...
Despite competitive pressures in the obesity market, long-term investors may stay invested in NVO stock due to strong demand ...
Kahn is a particular fan of the peptides NAD+ and glutathione—which, she says, “work synergistically to help with energy, ...
The common theme at the maker of Wegovy and at UnitedHealth may be investors' sudden awareness of cost-cutting pressure.
When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge ...
The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...
Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of ...
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
The Novo Nordisk Foundation started a dialog with Novo’s board “on the merits of an accelerated CEO succession,” Novo said, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results